Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the united states

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 5, 2011, Pages 549-556

  Tsai, Vivian ^a   Goldstein, Mary K ^a,b   Hsia, Henry H ^a   Wang, Yongfei ^c   Curtis, Jeptha ^c   Heidenreich, Paul A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Aging; Complications; Implantable cardioverter defibrillator; Registries

Indexed keywords

AGE; AGED; ARTERIOVENOUS FISTULA; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DEFIBRILLATOR; DIABETES MELLITUS; ELECTIVE SURGERY; EMBOLISM; ENDOPROSTHESIS LOOSENING; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART INJURY; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HUMAN; IMPLANTATION; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFORATION; PERIOPERATIVE COMPLICATION; PERIPHERAL NERVE INJURY; PNEUMOTHORAX; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; SENESCENCE; STROKE; THORAX SURGERY; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOMYOPATHIES; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ARREST; HUMANS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RISK; SURVIVAL ANALYSIS; UNITED STATES;

EID: 80054765571     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.959205     Document Type: Article

References (39)

1. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517-1524 (Pubitemid 47529385)
2. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, Alter DA, Laupacis A. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49:2408-2415 (Pubitemid 46962260)
3. Sweeney MO, Hellkamp AS, Ellenbogen KA, Lamas GA. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (most): Implications for device selection in elderly patients with sinus node disease. J Cardiovasc Electrophysiol. 2008;19: 1160-1166
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp- Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237 (Pubitemid 40110811)
5. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2:16-24
6. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18:833-838 (Pubitemid 47093069)
7. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm. 2008;5:646-653
8. Day JC. Population projections of the united states by age, sex, race, and Hispanic origin: 1995 to 2050. Curr Population Rep. 1996:25-1130
9. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2008: Key indicators of well-being. Federal Interagency Forum on Aging- Related Statistics. 2008:1-149
10. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the united states: 1993-2006. Pacing Clin Electrophysiol. 2010;33:705-711
11. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;301:1661-1670
12. Epstein AE, Kay GN, Plumb VJ, McElderry HT, Doppalapudi H, Yamada T, Shafiroff J, Syed ZA, Shkurovich S. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009;6:1136-1143
13. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883 (Pubitemid 34984635)
14. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937-1945 (Pubitemid 30419088)
15. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933-1940 (Pubitemid 26428217)
16. Grimm W, Stula A, Sharkova J, Alter P, Maisch B. Outcomes of elderly recipients of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2007;30(Suppl 1):S134-S138 (Pubitemid 46121827)
17. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2005;14: 169-173 (Pubitemid 43130288)
18. Noseworthy PA, Lashevsky I, Dorian P, Greene M, Cvitkovic S, Newman D. Feasibility of implantable cardioverter defibrillator use in elderly patients: A case series of octogenarians. Pacing Clin Electrophysiol. 2004;27:373-378 (Pubitemid 38352520)
19. Ermis C, Zhu AX, Vanheel L, Sakaguchi RN, Lurie KG, Lu F, Benditt DG. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patientsα75 and patientsα75 years of age treated with implantable cardioverter defibrillators. Europace. 2007;9:270-274 (Pubitemid 47079241)
20. Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, Badhwar N, Lee B, Varosy PD. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008;10: 1296-1301
21. Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S, Biehl M, Keelan ET, Jazayeri MR, Akhtar M, Dhala A. Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol. 1997;29:556-560 (Pubitemid 27116097)
22. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverterdefibrillators. J Am Coll Cardiol. 2006;47:2493-2497 (Pubitemid 43866387)
23. Haqqani HM, Mond HG. The implantable cardioverter-defibrillator lead: Principles, progress, and promises. Pacing Clin Electrophysiol. 2009;32: 1336-1353
24. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. Arch Intern Med. 2010;170:631-637
25. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4:1260-1263 (Pubitemid 47324135)
26. Anderson HV, Shaw RE, Brindis RG, Hewitt K, Krone RJ, Block PC, McKay CR, Weintraub WS. A contemporary overview of percutaneous coronary interventions: The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2002; 39:1096-1103 (Pubitemid 34267410)
27. Schafer JL. Multiple imputation: A primer. Stat Methods Med Res. 1999; 8:3-15 (Pubitemid 29222784)
28. Yarnoz MJ, Curtis AB. Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient. Am J Geriatr Cardiol. 2006;15:367-371
29. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158 (Pubitemid 38637995)
30. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1: 240-249
31. Chae SH, Koelling TM. Patient and physician determinants of implantable cardioverter defibrillator use in the heart failure population. Congest Heart Fail. 2010;16:141-146
32. Voigt A, Ezzeddine R, Barrington W, Obiaha-Ngwu O, Ganz LI, London B, Saba S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the united states from 1996 to 2001. J Am Coll Cardiol. 2004;44:855-858 (Pubitemid 39099585)
33. Day J. Population projections of the United States, by age, sex, race, and Hispanic origin: 1993 to 2050. Washington, DC: U.S. Government Printing Office; 1993:1104
34. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078-1084
35. Lee D, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson C, Khaykin Y, Cameron D, Janmohamed A, Yee J, Austin PC, Chen Z, Hardy J, Tu JV. Evaluation of early complications related to de novo cardioverte defibrillator implantation: Insights from the Ontario ICD Database. J Am Coll Cardiol. 2010;55:774-782
36. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics: 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-486
37. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119:167 e117-e121
38. Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA. Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria? Am Heart J. 2009;158:224-229
39. Polanczyk CA, Marcantonio E, Goldman L, Rohde LE, Orav J, Mangione CM, Lee TH. Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med. 2001; 134:637-643. (Pubitemid 32322241)